Coexistence of early onset sarcoidosis and partial interferon-γ receptor 1 deficiency.

Pediatric sarcoidosis comprises a spectrum of childhood granulomatous inflammatory conditions. Pathological hallmark of the disease is granuloma formation that is seen in the affected tissues and almost any organ or system can be involved. There are two forms of pediatric sarcoidosis. One is seen in older children and the clinical picture is very similar to that of adult sarcoidosis and the other one is seen in early childhood. Sarcoidosis in early childhood can be divided as Blau syndrome (familial form) and early onset sarcoidosis (sporadic form). In both of the diseases there is a defect in the NOD2/CARD15 gene. The typical triad of early onset sarcoidosis is polyarthritis, dermatitis and uveitis. Interferon-γ receptor 1 deficiency is caused by defects in the IFNγR1 gene and non-tuberculosis mycobacterial pathogens are the leading causes of infections that start in early childhood. Herein we report a patient who presented with the symptoms of early onset sarcoidosis and also had partial interferon-γ receptor 1 deficiency that presented with BCG-osis. In addition to anti-mycobacterial treatment, methotrexate and prednisolone were used in therapy.

[1]  L. Punzi,et al.  Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease , 2015, RMD Open.

[2]  J. Casanova,et al.  Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. , 2014, Seminars in immunology.

[3]  L. Punzi,et al.  Monogenic Autoinflammatory Syndromes: State of the Art on Genetic, Clinical, and Therapeutic Issues , 2013, International journal of rheumatology.

[4]  J. Casanova,et al.  Granulomatous skin lesions, severe scrotal and lower limb edema due to mycobacterial infections in a child with complete IFN-γ receptor-1 deficiency. , 2012, Immunotherapy.

[5]  J. Yagüe,et al.  NOD2-associated pediatric granulomatous arthritis, an expanding phenotype: study of an international registry and a national cohort in Spain. , 2009, Arthritis and rheumatism.

[6]  J. Casanova,et al.  The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. , 2008, The Journal of allergy and clinical immunology.

[7]  J. Yagüe,et al.  NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort. , 2007, Arthritis and rheumatism.

[8]  A. Utani,et al.  Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. , 2004, Blood.

[9]  E. Mallon,et al.  Juvenile sarcoidosis after BCG vaccination. , 2003, Journal of the American Academy of Dermatology.

[10]  G. Thomas,et al.  CARD15 mutations in Blau syndrome , 2001, Nature Genetics.

[11]  A. Hance,et al.  Mycobacteria and sarcoidosis: an overview and summary of recent molecular biological data. , 1995, Sarcoidosis.

[12]  J. McFadden,et al.  Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction , 1992, The Lancet.

[13]  C. Wouters,et al.  Chapter 35 – PEDIATRIC SARCOIDOSIS , 2011 .

[14]  T. Nakahata,et al.  A case of early-onset sarcoidosis with a six-base deletion in the NOD2 gene. , 2010, Rheumatology.

[15]  T. Nakahata,et al.  Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis. , 2009, Arthritis and rheumatism.

[16]  M. Newport,et al.  Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. , 2004, Lancet.

[17]  C. Fink,et al.  Early onset sarcoidosis: not a benign disease. , 1997, The Journal of rheumatology.